THIRD AMENDMENT TO EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • November 14th, 2024 • Kairos Pharma, LTD. • Pharmaceutical preparations
THIS THIRD AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT (this “Amendment”) is made and entered into as of November 13, 2024 (“Amendment Effective Date”), by and between CEDARS-SINAI MEDICAL CENTER, a California nonprofit public benefit corporation (“CSMC”) and KAIROS PHARMA, LTD., a California corporation (“Licensee”), under the following circumstances:
PURCHASE AGREEMENTPurchase Agreement • November 14th, 2024 • Kairos Pharma, LTD. • Pharmaceutical preparations • New York
THIS PURCHASE AGREEMENT (this “Agreement”), dated as of November 12, 2024 (the “Effective Date”), is made by and between HELENA GLOBAL INVESTMENT OPPORTUNITIES I LTD. (the “Investor”), and KAIROS PHARMA, LTD., a Delaware corporation (the “Company”).
FOURTH AMENDMENT TO EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • November 14th, 2024 • Kairos Pharma, LTD. • Pharmaceutical preparations
THIS FOURTH AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT (this “Amendment”) is made and entered into as of November 13, 2024 (“Amendment Effective Date”), by and between CEDARS-SINAI MEDICAL CENTER, a California nonprofit public benefit corporation (“CSMC”) and ENVIRO THERAPEUTICS, INC., a California corporation (“Licensee”), under the following circumstances:
SECOND CONVERSION AGREEMENTConversion Agreement • November 14th, 2024 • Kairos Pharma, LTD. • Pharmaceutical preparations • California
This SECOND CONVERSION AGREEMENT (this “Agreement”) is made and entered into as of November 13, 2024 (“Effective Date”), by and between Cedars-Sinai Medical Center, a California nonprofit public benefit corporation (“Cedars-Sinai”), on the one hand, and Kairos Pharma, Ltd., a Delaware corporation (“Kairos”), and Enviro Therapeutics, Inc., a California corporation and wholly-owned subsidiary of Kairos (“Enviro” and together with Kairos, the “Company”), on the other hand.
AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • November 14th, 2024 • Kairos Pharma, LTD. • Pharmaceutical preparations
This Amendment No. 1 (the “Amendment”) to the Employment Agreement (the “Original Employment Agreement”), originally dated September 27, 2023, is hereby entered into as of the 11th day of November 2024, by and between Kairos Pharma, Ltd., a Delaware corporation (the “Company”), and Neil Bhowmick (the “Executive”). Terms not otherwise defined herein shall have the meaning set forth in the Original Employment Agreement
AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • November 14th, 2024 • Kairos Pharma, LTD. • Pharmaceutical preparations
This Amendment No. 1 (the “Amendment”) to the Employment Agreement (the “Original Employment Agreement”), originally dated September 27, 2023, is hereby entered into as of the 11th day of November 2024, by and between Kairos Pharma, Ltd., a Delaware corporation (the “Company”), and Ramachandran Murali (the “Executive”). Terms not otherwise defined herein shall have the meaning set forth in the Original Employment Agreement
AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • November 14th, 2024 • Kairos Pharma, LTD. • Pharmaceutical preparations
This Amendment No. 1 (the “Amendment”) to the Employment Agreement (the “Original Employment Agreement”), originally dated September 27, 2023, is hereby entered into as of the 11th day of November 2024, by and between Kairos Pharma, Ltd., a Delaware corporation (the “Company”), and John Yu (the “Executive”). Terms not otherwise defined herein shall have the meaning set forth in the Original Employment Agreement
AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • November 14th, 2024 • Kairos Pharma, LTD. • Pharmaceutical preparations
This Amendment No. 1 (the “Amendment”) to the Employment Agreement (the “Original Employment Agreement”), originally dated September 27, 2023, is hereby entered into as of the ____ day of November 2024, by and between Kairos Pharma, Ltd., a Delaware corporation (the “Company”), and Doug Samuelson (the “Executive”). Terms not otherwise defined herein shall have the meaning set forth in the Original Employment Agreement
